DEXLEVO's core product is GOURI, a liquid polymer filler that the company says regenerates collagen in addition to providing cosmetic anti‑aging effects. The company secured CE certification for GOURI in May and launched the brand at the Aesthetic and Anti‑aging Medicine World Congress, where it also signed a $30 million supply contract with overseas buyers. DEXLEVO completed KRW 26 billion in pre‑IPO funding, which set a pre‑investment valuation at KRW 250 billion, reflecting strong commercialization momentum. The proceeds will be used to build a new cGMP‑grade production facility in Songdo and to fund aggressive marketing of its flagship product. DEXLEVO was founded in 2013 by CEO Jaewon Yoo and plans to pursue a KOSDAQ listing around 2023 with Hana Financial Investment as lead underwriter.

Total raised

$22M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2021